FIRM FIXED PRICENO SET ASIDE USED.
TEVA PHARMACEUTICALS USA, INC. - NEW AWARD FOR GLATIRAMER ACETATE INJECTIONS WITH TEVA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS AUGUST 5, 2023 TO AUGUST 4, 2024 WITH FOUR ONE-YEAR OPTIONS.
PIID: 36E79723D0023Solicitation ID: 36E79723R0012
Signed Date: Dec 3, 2025Effective Date: Aug 5, 2023
Vendor
TEVA PHARMACEUTICALS USA, INC.
NAICS
325412
Signed Date
Dec 3, 2025
Key Details
Description
NEW AWARD FOR GLATIRAMER ACETATE INJECTIONS WITH TEVA PHARMACEUTICALS USA, INC. ORDERING PERIOD IS AUGUST 5, 2023 TO AUGUST 4, 2024 WITH FOUR ONE-YEAR OPTIONS.
Context & Analysis
On Dec 3, 2025, Department of Veterans Affairs to TEVA PHARMACEUTICALS USA, INC. for new award for glatiramer acetate injections with teva pharmaceuticals usa, inc. ordering period is august 5, 2023 to august 4, 2024 with four one-year options.. The award is classified under NAICS 325412 — PHARMACEUTICAL PREPARATION MANUFACTURING and issued as a firm fixed price contract. Competition extent: full and open competition with 3 offers received. The procurement used a NO SET ASIDE USED. set-aside.
Contractor Information
Stay Updated
Get notified about new opportunities matching your interests.